tradingkey.logo


tradingkey.logo


Alcon AG

ALC
75.260USD
+1.020+1.37%
āļ›āļīāļ” 03/25, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
36.78BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
37.88P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Alcon AG āļšāļĢāļīāļĐāļąāļ—

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.

āļ‚āđ‰āļ­āļĄāļđāļĨ Alcon AG


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™ALC
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Alcon AG
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļApr 09, 2019
āļ‹āļĩāļ­āļĩāđ‚āļ­Endicott (David J)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™25599
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Apr 09
āļ—āļĩāđˆāļ­āļĒāļđāđˆRue Louis d'Affry 6
āđ€āļĄāļ·āļ­āļ‡FRIBOURG
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻSwitzerland
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ1700
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ41589113800
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.alcon.ch/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™ALC
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļApr 09, 2019
āļ‹āļĩāļ­āļĩāđ‚āļ­Endicott (David J)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Alcon AG


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
269.77K
+23.23%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
140.55K
+4.49%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
48.83K
--
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
47.49K
+36.34%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
41.42K
+31.62%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
21.91K
-3.22%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
18.84K
+8.38%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
13.81K
+12.53%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
12.42K
+11.96%
Ms. Deborah Di Sanzo
Ms. Deborah Di Sanzo
Director
Director
450.00
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
269.77K
+23.23%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
140.55K
+4.49%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
48.83K
--
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer, Senior Vice President
Chief Operating Officer, Senior Vice President
47.49K
+36.34%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
41.42K
+31.62%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
21.91K
-3.22%

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Consumables
745.00M
28.78%
Contact lenses
707.00M
27.31%
Ocular health
462.00M
17.84%
Implantables
432.00M
16.69%
Equipment/other
243.00M
9.39%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
International
1.42B
54.92%
United States
1.17B
45.08%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Consumables
745.00M
28.78%
Contact lenses
707.00M
27.31%
Ocular health
462.00M
17.84%
Implantables
432.00M
16.69%
Equipment/other
243.00M
9.39%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 21 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 21 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.25%
Norges Bank Investment Management (NBIM)
2.41%
UBS Fund Management (Switzerland) AG
2.29%
Aristotle Capital Management, LLC
2.21%
āļ­āļ·āđˆāļ™ āđ†
83.89%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
4.25%
Norges Bank Investment Management (NBIM)
2.41%
UBS Fund Management (Switzerland) AG
2.29%
Aristotle Capital Management, LLC
2.21%
āļ­āļ·āđˆāļ™ āđ†
83.89%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
29.68%
Investment Advisor/Hedge Fund
24.94%
Bank and Trust
4.17%
Hedge Fund
3.48%
Sovereign Wealth Fund
2.49%
Pension Fund
1.68%
Research Firm
1.65%
Individual Investor
0.17%
Insurance Company
0.09%
āļ­āļ·āđˆāļ™ āđ†
31.64%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
1623
342.44M
72.26%
+507.76K
2025Q3
1664
342.40M
72.42%
-9.24M
2025Q2
1658
350.50M
70.82%
+3.47M
2025Q1
1649
340.47M
77.49%
-46.78M
2024Q4
1637
370.92M
68.31%
+36.10M
2024Q3
1614
334.31M
67.55%
+3.20M
2024Q2
1581
336.83M
74.41%
-28.77M
2024Q1
1567
336.16M
66.45%
+4.09M
2023Q4
1583
325.43M
67.42%
+1.37M
2023Q3
1565
323.23M
69.34%
-9.13M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
20.97M
4.2%
+321.27K
+1.56%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
11.35M
2.27%
-1.28M
-10.12%
Jun 30, 2025
UBS Fund Management (Switzerland) AG
11.47M
2.29%
-68.71K
-0.60%
Jun 30, 2025
Aristotle Capital Management, LLC
10.71M
2.14%
-1.33M
-11.06%
Sep 30, 2025
ZÞrcher Kantonalbank (Asset Management)
8.49M
1.7%
-648.99K
-7.10%
Sep 30, 2025
AKO Capital LLP
7.97M
1.6%
+260.96K
+3.38%
Sep 30, 2025
Fidelity Management & Research Company LLC
7.45M
1.49%
-2.76M
-27.02%
Sep 30, 2025
Select Equity Group, L.P.
6.73M
1.35%
-34.72K
-0.51%
Sep 30, 2025
Pictet Asset Management Ltd.
4.81M
0.96%
-68.93K
-1.41%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Global X Aging Population ETF
2.36%
Franklin FTSE Switzerland ETF
2.28%
iShares MSCI Switzerland ETF
2.2%
First Trust Indxx Medical Devices ETF
2.06%
Running Oak Efficient Growth ETF
1.77%
Global X S&P Catholic Values Developed ex-US ETF
1.07%
JPMorgan BetaBuilders Europe ETF
0.59%
iShares Global Healthcare ETF
0.53%
ALPS O'Shares International Developed Quality Dividend ETF
0.45%
Wahed Dow Jones Islamic World ETF
0.44%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Global X Aging Population ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.36%
Franklin FTSE Switzerland ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.28%
iShares MSCI Switzerland ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.2%
First Trust Indxx Medical Devices ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.06%
Running Oak Efficient Growth ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.77%
Global X S&P Catholic Values Developed ex-US ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.07%
JPMorgan BetaBuilders Europe ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.59%
iShares Global Healthcare ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.53%
ALPS O'Shares International Developed Quality Dividend ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.45%
Wahed Dow Jones Islamic World ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.44%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 400.00M USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™